What is the Procedure for Body Contouring Post GLP-1 Weight Loss
Outcomes vary with age, sleep, training, and diet, and depend on consistent, supervised use
Tirzepatide, a dual GIP/GLP-1 agonist, became the first FDA-approved medication for moderate to severe obstructive sleep apnea in adults with obesity
Participants who received the highest dose of orforglipron, 36 milligrams, lost 11.2% of their body weight - about 25 pounds on average - over more than 16 months
GET YOUR FREE E-COPY 2025 My Food Bag Ltd
She holds an MA in digital journalism and has contributed to other outlets including Seventeen, Teen Vogue, MamsLatinas, Bustle, and more